Charles J Bieberich | Academic Influence

Charles J Bieberich's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Papers

The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice (539)
Prostate-specific and Androgen-dependent Expression of a Novel Homeobox Gene* (248)
MYC and Prostate Cancer. (225)
Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. (218)
Role of the major histocompatibility complex class I antigens in tumor growth and metastasis. (195)
Immunohistochemical Differentiation of High-grade Prostate Carcinoma From Urothelial Carcinoma (183)
ERG gene rearrangements are common in prostatic small cell carcinomas (182)
NKX3.1 as a Marker of Prostatic Origin in Metastatic Tumors (179)
A targeting modality for destruction of RNA polymerase I that possesses anticancer activity. (177)
Functional and molecular features of the Id4+ germline stem cell population in mouse testes. (171)
Natural Killer Cell Tolerance in Mice with Mosaic Expression of Major Histocompatibility Complex Class I Transgene (146)
Decreased NKX3.1 Protein Expression in Focal Prostatic Atrophy, Prostatic Intraepithelial Neoplasia, and Adenocarcinoma: Association with Gleason Score and Chromosome 8p Deletion (135)
Altering the boundaries of Hox3.1 expression: Evidence for antipodal gene regulation (124)
MYC Overexpression Induces Prostatic Intraepithelial Neoplasia and Loss of Nkx3.1 in Mouse Luminal Epithelial Cells (123)
Influence of neonatal estrogens on rat prostate development. (116)
Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice (104)
NKX-3.1 interacts with prostate-derived Ets factor and regulates the activity of the PSA promoter. (100)
Regulation of Hoxc-8 during mouse embryonic development: identification and characterization of critical elements involved in early neural tube expression. (85)
Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate (73)
Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer. (72)
Androgen‐independent expression of hoxb‐13 in the mouse prostate (72)
Evidence for positive and negative regulation of the Hox-3.1 gene. (71)
Regulated expression of a murine class I gene in transgenic mice. (69)
Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion. (66)
Loss of Nkx3.1 expression in bacterial prostatitis: a potential link between inflammation and neoplasia. (66)
Differential Expression of the Hox 3.1 Gene in Adult Mouse Skin (55)
The visna virus long terminal repeat directs expression of a reporter gene in activated macrophages, lymphocytes, and the central nervous systems of transgenic mice (54)
NKX3.1 Is Regulated by Protein Kinase CK2 in Prostate Tumor Cells (54)
Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy. (51)
Tyrosine kinase Etk/BMX is up-regulated in human prostate cancer and its overexpression induces prostate intraepithelial neoplasia in mouse. (51)
Ubiquitination by TOPORS Regulates the Prostate Tumor Suppressor NKX3.1* (50)
The effects of green and blue-green algal diets on the reproductive rate of the rotifer Brachionus plicatilis (46)
Hematopoietic progenitor cell abnormalities in Hoxc-8 null mutant mice. (44)
Ets Family Protein, Erg Expression in Developing and Adult Mouse Tissues by a Highly Specific Monoclonal Antibody (41)
Gain of function mutations for paralogous Hox genes: implications for the evolution of Hox gene function. (40)
A regulatory region from the mouse Hox-2.2 promoter directs gene expression into developing limbs. (37)
A transgenic model of transactivation by the Tax protein of HTLV-I. (34)
Protein Kinase A Regulates MYC Protein through Transcriptional and Post-translational Mechanisms in a Catalytic Subunit Isoform-specific Manner* (32)
Structural analysis of the Hox-3.1 transcription unit and the Hox-3.2--Hox-3.1 intergenic region. (30)
Distinct regulatory elements mediate the dynamic expression pattern of Nkx3.1 (29)
Structural and functional analysis of domains mediating interaction between NKX‐3.1 and PDEF (29)
Hoxb13 regulatory elements mediate transgene expression during prostate organogenesis and carcinogenesis (26)
Loss of Nkx3.1 expression in the transgenic adenocarcinoma of mouse prostate model (24)
A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland (23)
Serial displacement chromatofocusing and its applications in multidimensional chromatography and gel electrophoresis: II. Experimental results. (22)
Stabilization of the prostate‐specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim‐1 in prostate cancer cells (21)
The reverse in-gel kinase assay to profile physiological kinase substrates (20)
Regulating NKX3.1 stability and function: Post‐translational modifications and structural determinants (19)
Functional expression of a heterologous major histocompatibility complex class I gene in transgenic mice. (19)
Prostate cancer: New answers prompt new questions regarding cell of origin (19)
Consequences of interleukin 1β‐triggered chronic inflammation in the mouse prostate gland: Altered architecture associated with prolonged CD4+ infiltration mimics human proliferative inflammatory atrophy (17)
A transgenic class I antigen is recognized as self and functions as a restriction element. (15)
Identification of infusion strategy for achieving repeatable nanoparticle distribution and quantification of thermal dosage using micro-CT Hounsfield unit in magnetic nanoparticle hyperthermia (15)
Functional specificity of Hoxa-4 in vertebral patterning lies outside of the homeodomain. (15)
Gene transfer into mice. (14)
Decreased NKX 3 . 1 Protein Expression in Focal Prostatic Atrophy , Prostatic Intraepithelial Neoplasia , and Adenocarcinoma : Association with Gleason Score and Chromosome 8 p Deletion (14)
Evolving concepts in molecular pathology (14)
Phosphorylation of NuMA by Aurora‐A kinase in PC‐3 prostate cancer cells affects proliferation, survival, and interphase NuMA localization (13)
ETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer Development (12)
If this is true, what does it imply? How end-user antibody validation facilitates insights into biology and disease (11)
Castration-mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer Progression (11)
7 – Molecular Approaches Involved in Mammalian Gene Transfer: Analysis of Transgene Integration (11)
Proline-mediated Proteasomal Degradation of the Prostate-specific Tumor Suppressor NKX3.1* (10)
Effective targeting of RNA polymerase I in treatment‐resistant prostate cancer (10)
Reducing sample complexity in proteomics by chromatofocusing with simple buffer mixtures. (9)
Treatment efficacy of laser photothermal therapy using gold nanorods (9)
A Hoxb13‐driven reverse tetracycline transactivator system for conditional gene expression in the prostate (9)
Erratum: ETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer Development (8)
Nanoparticle Redistribution in PC3 Tumors Induced by Local Heating in Magnetic Nanoparticle Hyperthermia: In Vivo Experimental Study (8)
Differential effects on T cell and NK cell development by tissue‐specific expression of H‐2Dd transgene (7)
Protein Kinase CK2 Controls the Stability of Prostate Derived ETS Factor (7)
Ventral prostate predominant l, a novel mouse gene expressed exclusively in the prostate * (7)
Quantitative proteomic analysis of a genetically induced prostate inflammation mouse model via custom 4-plex DiLeu isobaric labeling. (6)
Treatment Efficacy for Validating MicroCT-Based Theoretical Simulation Approach in Magnetic Nanoparticle Hyperthermia for Cancer Treatment (6)
MicroCT Imaging and In Vivo Temperature Elevations in Implanted Prostatic Tumors in Laser Photothermal Therapy Using Gold Nanorods (6)
Identification and validation of inhibitor-responsive kinase substrates using a new paradigm to measure kinase-specific protein phosphorylation index. (6)
Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models (6)
Quantifying Kinase-Specific Phosphorylation Stoichiometry Using Stable Isotope Labeling In a Reverse In-Gel Kinase Assay. (5)
Comprehensive urinary metabolomic characterization of a genetically induced mouse model of prostatic inflammation. (5)
Regulating gene expression in transgenic animals. (4)
Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression. (4)
8 – Molecular Approaches Involved in Mammalian Gene Transfer: Evaluation of Transgene Expression (3)
Abstract 1086: MYC overexpression combined with Pten loss generates genomic instability and rapid metastasis in a new mouse model of lethal prostate adenocarcinoma. (3)
Characterization of novel cell lines derived from a MYC‐driven murine model of lethal metastatic adenocarcinoma of the prostate (3)
Abstract 1619: Discovering a new physiological substrate of Aurora-A kinase (3)
New answers prompt new questions regarding cell of origin: Prostate cancer (2)
Transgenic mice in the study of immunology (2)
Regulating gene expression in transgenic animals (2)
Mild Whole-Body Hyperthermia-Induced Interstitial Fluid Pressure Reduction and Enhanced Nanoparticle Delivery to PC3 Tumors: In Vivo Studies and Micro-Computed Tomography Analyses (2)
PARADOXICAL DOWNREGULATION OF C-MYC AND UPREGULATION OF NKX3.1 PROTEINS DURING INVASION IN THE Lo-MYC MOUSE PROSTATE (1)
Mild Whole Body Hyperthermia Induced Interstitial Fluid Pressure (IFP) Reduction and Enhanced Nanoparticle Delivery to PC3 Tumors: In Vivo Studies and MicroCT Analyses (1)
Nanoparticle Delivery in Prostate Tumors Implanted in Mice Facilitated by Either Local or Whole-Body Heating (0)
Visualization and quantification of gold nanorods distribution in prostatic tumors using microct imaging (0)
Functional expression of a heterologous major histocompatibility complex class I gene in transgenic mice (0)
Thermal Effect of Gold Nanorods in Implanted Prostatic Tumors During Laser Photothermal Therapy (0)
Molecular Basis of Prostate-Specific Androgen-Independent Expression of a Homeobox Gene (0)
Abstract 4287: Ets-related gene (Erg) expression in developing and adult mouse tissues (0)
Abstract A010: ETS-related gene mediated androgen receptor aggregation and endoplasmic reticulum stress in prostate cancer development (0)
Temperature Elevations in Implanted Prostatic Tumors During Laser Photothermal Therapy Using Nanorods (0)
Shared TP 53 GeneMutation inMorphologically and PhenotypicallyDistinct Concurrent Primary Small CellNeuroendocrineCarcinoma and Adenocarcinomaof the Prostate (0)
AWARD NUMBER: W81XWH-15-1-0730 TITLE: MYC RNAi-PT Combination Nanotherapy for Metastatic Prostate Cancer Treatment PRINCIPAL INVESTIGATOR: Charles J. Bieberich CONTRACTING ORGANIZATION: UNIVERSITY OF MARYLAND BALTIMORE COUNTY (0)
Abstract 1270: Identification and functional analysis of Pim-1 kinase substrates in prostate cancer (0)
Getting to the Core of It All: Nanocapsules to Mitigate Infusion Reactions Can Promote Hemostasis and Be a Platform for Intravenous Therapies. (0)
MYC RNAi-Pt Combination Nanotherapy for Metastatic Prostate Cancer Treatment (0)
Abstract 4175: ERG oncogenic activation leads to the endoplasmic reticulum stress and cell survival mechanisms (0)
Advances in Brief NKX-3 . 1 Interacts with Prostate-derived Ets Factor and Regulates the Activity of the PSA Promoter 1 (0)
Treatment efficacy of laser photothermal therapy using gold nanorods: Tumor shrinkage study (0)
Breakdown of ‘Tolerance’ in the Natural Killer Interaction with H-2 Syngeneic Grafts (0)
Concurrent Treatment with Pim Kinase Inhibitor Downregulates Alternative Non-Homologous End-Joining Repair and Decreases Genomic Instability in FLT3-ITD Cells Treated with Topoisomerase 2 Inhibitor Chemotherapy Drugs (0)
Abstract 2361: Pim kinase inhibition alters mRNA splicing in AML cell lines (0)
Intraepithelial Neoplasia in Mouse Cancer and Its Overexpression Induces Prostate Tyrosine Kinase Etk / BMX Is Up-regulated in Human Prostate (0)
Shared P53 gene mutation and gene expression in concurrent small cell and acinar adenocarcinoma of the prostate. (0)
Abstract LB-160: Human telomerase RNA component (hTR/TERC) is consistently overexpressed in prostate cancer, required for cell proliferation and is positively regulated by MYC (0)
MP84-10 ERG INDUCES ENDOPLASMIC RETICULUM STRESS (ER) AND UNFOLDED PROTEIN RESPONSE (UPR) TO INITIATE PROSTATE CANCER CARCINOGENESIS (0)
Identifying Physiological Substrates of the Snf-1-Related Kinase Hunk: New Biomarkers of Kinase Activity and Therapeutic Targets in Metastatic Breast Cancer (0)
Regulated expression of a murine class I gene in transgenic mice (0)
Temperature elevations in prostatic tumors during laser photothermal therapy (0)
Regulation of tumor suppressor NKX3.1 by ubiquitination (0)
Single-cell atlas of epithelial and stromal cell heterogeneity by lobe and strain in the mouse prostate (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Charles J Bieberich?

Charles J Bieberich is affiliated with the following schools: